Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 148

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 8
Chunk 148
---
 levied in accordance with the US Treaty. Shareholders should obtain specialist taxation advice in these circumstances.

No stamp duty

A transfer of shares of an
Australian company, such as Radiopharm, that is listed on the Australian Securities Exchange is generally not subject to Australian stamp
duty.

No Australian death duty / estate tax

Australia does not have any
estate tax or death duties. In general, no capital gains tax liability is realized upon the inheritance of a deceased person’s shares
pursuant to the deceased’s will.

Goods and Services Tax

The issue or transfer of shares will not incur
Australian goods and services tax.

F. Dividends and Paying Agents

Not applicable.

G. Statement by Experts

Not applicable.

H. Documents on Display

We are subject to the reporting
requirements of the U. S. Securities Exchange Act of 1934, as amended, or the Exchange Act, as applicable to “foreign private issuers”
as defined in Rule 3b-4 under the Exchange Act. As a foreign private issuer, we are exempt from certain provisions of the Exchange Act.
Accordingly, our proxy solicitations are not subject to the disclosure and procedural requirements of regulation 14A under the Exchange
Act, transactions in our equity securities by our officers and directors are exempt from reporting and the “short-swing” profit
recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file
periodic reports and financial statements as frequently or as promptly as U. S. companies whose securities are registered under the Exchange
Act. However, we file with the U. S. Securities and Exchange Commission an annual report on Form 20-F containing financial statements that
have been examined and reported on, with and opinion expressed by an independent registered public accounting firm, and we submit reports
to the U. S. Securities and Exchange Commission on Form 6-K containing (among other things) press releases and unaudited financial
information for the first six months of each fiscal year. We post our annual and half-year reports on our website promptly following their
filing with the U. S. Securities and Exchange Commission. The information contained on our website or available through our website is
not incorporated by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website
in this Annual Report on Form 20-F is an inactive textual reference only.

This document and the